These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 813772)

  • 1. Proton nuclear magnetic resonance studies of Nepsilon-Me-His2-thyroliberin. An hyperactive analogue of thyroliberin (thyrotropin-releasing factor).
    Bellocq AM; Dubien M
    Biochim Biophys Acta; 1976 Jan; 420(1):1-7. PubMed ID: 813772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational analysis of an analogue of thyroliberin (T.R.F.).
    Bellocq AM; Castensson S; Sievertsson H
    Biochem Biophys Res Commun; 1977 Jan; 74(2):577-83. PubMed ID: 402135
    [No Abstract]   [Full Text] [Related]  

  • 3. Proton magnetic resonance comparison of neurohypophyseal hormones and analogs: deletion of amino groups and the conformation of lysine vasopressin.
    Glickson JD; Urry DW; Havran RT; Walter R
    Proc Natl Acad Sci U S A; 1972 Aug; 69(8):2136-40. PubMed ID: 4506084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and conformational studies by 1H- and 13C-NMR spectroscopy of a novel, sterically constrained analogue of thyrotropin-releasing hormone.
    Mapelli C; Van Halbeek H; Stammer CH
    Biopolymers; 1990 Feb; 29(2):407-22. PubMed ID: 2158826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method for correlation of proton magnetic resonance assignments in different solvents: conformational transition of oxytocin and lysine vasopressin from dimethylsulfoxide to water.
    Glickson JD; Urry DW; Walter R
    Proc Natl Acad Sci U S A; 1972 Sep; 69(9):2566-9. PubMed ID: 4506776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray conformational analysis of the potent thyroliberin analogue L-pyroglutamyl-beta-(2-thienyl)-L-analyl-L-prolinamide.
    Stensland B; Castensson S
    J Mol Biol; 1982 Oct; 161(2):257-68. PubMed ID: 6818354
    [No Abstract]   [Full Text] [Related]  

  • 7. 13C-nuclear magnetic resonance study of [85% 13C-enriched proline]thyrotropin releasing factor: 13C-13C vicinal coupling constants and conformation of the proline residue.
    Haar W; Fermandjian S; Vicar J; Blaha K; Fromageot P
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):4948-52. PubMed ID: 813218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational analysis of NMR of an analogue of thyrotropin releasing factor: the tripeptide is less than Glu-Leu-Pro-A.
    Bellocq AM; Dubien M; Dupart E
    Biochem Biophys Res Commun; 1975 Aug; 65(4):1393-9. PubMed ID: 829894
    [No Abstract]   [Full Text] [Related]  

  • 9. s-Cis and s-trans isomerism of the His-Pro peptide bond in angiotensin and thyroliberin analogues.
    Liakopoulou-Kyriakides M; Galardy RE
    Biochemistry; 1979 May; 18(10):1952-7. PubMed ID: 35219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis of thyrotropin releasing factor by proton magnetic resonance spectroscopy.
    Montagut M; Lemanceau B; Bellocq AM
    Biopolymers; 1974 Dec; 13(12):2615-29. PubMed ID: 4216374
    [No Abstract]   [Full Text] [Related]  

  • 11. Conformational studies on arginine vasopressin and arginine vasotocin by proton magnetic resonance spectroscopy.
    Walter R; Ballardin A; Schwartz IL; Gibbons WA; Wyssbrod HR
    Proc Natl Acad Sci U S A; 1974 Nov; 71(11):4528-32. PubMed ID: 4530998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Statistical weights of conformers of thyroliberin molecule and the averaging of its calculated structural characteristics].
    Betin'sh IaR; Nikiforovich GV
    Bioorg Khim; 1984 Sep; 10(9):1177-82. PubMed ID: 6439221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation of lysine vasopressin: a comparison with oxytocin.
    Walter R; Glickson JD; Schwartz IL; Havran RT; Meienhofer J; Urry DW
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1920-4. PubMed ID: 4505670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conformational analysis of biologically active thyroliberin analogs by two-dimensional NMR spectroscopy].
    Gorbatiuk VIa; Shapiro IuE; Mazurov AA; Zhuravlev VG; Andronati SA; Korotenko TI; Romanovskiĭ PIa
    Bioorg Khim; 1992 Feb; 18(2):235-51. PubMed ID: 1605801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 300-MHz nuclear magnetic resonance study of oxytocin aqueous solution: conformational implications.
    Brewster AI; Hruby VJ
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3806-9. PubMed ID: 4521206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear magnetic resonance studies of lysine-vasopressin: structural constraints.
    Von Dreele PH; Brewster AI; Bovey FA; Scheraga HA; Ferger MF; Du Vigneaud V
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3088-91. PubMed ID: 5289251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational studies of oxytocin, lysine vasopressin, arginine vasopressin, and arginine vasotocin by carbon-13 nuclear magnetic resonance spectroscopy.
    Walter R; Prasad KU; Deslauriers R; Smith IC
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2086-90. PubMed ID: 4516207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin and neurohypophyseal peptides: spectral assignment and conformational analysis by 220 MHz nuclear magnetic resonance.
    Johnson LF; Schwartz IL; Walter R
    Proc Natl Acad Sci U S A; 1969 Dec; 64(4):1269-75. PubMed ID: 5271751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1H nuclear magnetic resonance studies of thyrotropin releasing factor (TRF).
    Feeney J; Bedford GR; Wessels PL
    FEBS Lett; 1974 Jun; 42(3):347-51. PubMed ID: 4369451
    [No Abstract]   [Full Text] [Related]  

  • 20. Conformational properties of 2,3-methanopyroglutamic acid in peptides: NMR and x-ray diffraction studies.
    Mapelli C; Elrod LF; Switzer FL; Stammer CH; Holt EM
    Biopolymers; 1989 Jan; 28(1):123-8. PubMed ID: 2497811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.